The patent relates to a novel polymorphic form (form II) of Rotigotine, which form is useful for the manufacture of a stable medicament for treating or alleviating symptoms .of Parkinson ’s disease and other dopamine-related disorders.
Brief outline of the case
No less than 7 oppositions had been filed.
The patent was revoked and the proprietor appealed.